주식회사셈스
주식회사셈스's KOBDi Score is 41.39 as of Sep 2026, up 2.90 points since Apr 2025; it rose in 4 and fell in 1 of the 12 monthly updates. As of Sep 2026 it is ahead of about 62% of companies in its industry, against 61% in Aug 2026 and 53% in Apr 2025. Its strongest position was 62% (Sep 2026) and its weakest 52% (Aug 2025).
A year earlier, in Aug 2025, its score was 38.46 and it was ahead of about 52% of companies in its industry.
| Sep 2026 | 41.39 | ahead of 62% |
| Aug 2026 | 41.06 | ahead of 61% |
| Jul 2026 | 41.06 | ahead of 62% |
| Jun 2026 | 38.68 | ahead of 54% |
| May 2026 | 38.68 | ahead of 54% |
| Apr 2026 | 38.68 | ahead of 54% |
| Mar 2026 | 38.68 | ahead of 54% |
| Feb 2026 | 38.62 | ahead of 54% |
| Dec 2025 | 38.62 | ahead of 54% |
| Aug 2025 | 38.46 | ahead of 52% |
| Jul 2025 | 38.50 | ahead of 53% |
| May 2025 | 38.50 | ahead of 55% |
| Apr 2025 | 38.50 | ahead of 53% |
| # | ||||
|---|---|---|---|---|
| (주)카바이오테라퓨틱스 Kabiotherapeutics Co., Ltd. | 1–4 | #479 | ||
| 주식회사전인치유알고리즘 | 1–4 | #480 | ||
| (주)에피큐어 Epicure Co., Ltd. | 1–4 | #477 | ||
| 주식회사프리벤티스트 Preventist Co., Ltd. | 1–4 | #481 | ||
| 인테론코리아(유) Interon Korea LLC | 1–4 | #476 | ||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
Where is 주식회사셈스 located?
주식회사셈스 is registered at 인천광역시 연수구 컨벤시아대로, South Korea (postal code 22004).
What industry is 주식회사셈스 in?
주식회사셈스 belongs to Professional, Scientific & Technical Services › Research & Development Services › Medical and pharmaceutical research and development industry.
How many employees does 주식회사셈스 have?
주식회사셈스 has 1–4 employees.
What is 주식회사셈스's KOBDi Score?
41.39 as of September 2026, ahead of about 62% of companies in its industry.
Who are 주식회사셈스's competitors?
Similar companies include Kabiotherapeutics, 주식회사전인치유알고리즘 and Epicure.